نتایج جستجو برای: nipt nanoparticles

تعداد نتایج: 107445  

2016
Guijie Qi Jianping Yi Baosheng Han Heng Liu Wanru Guo Chong Shi Lirong Yin

This study aimed to summarize the effects of noninvasive prenatal testing (NIPT) on aneuploidy among high-risk participants in Tangshan Maternal and Children Health Hospital.NIPT or invasive prenatal diagnosis was recommended to patients with a high risk of fetal aneuploidy from February 2013 to February 2014. Patients who exhibited eligibility and applied for NIPT from January 2012 to January ...

2016
Dick Oepkes G. C. (Lieve) Page‐Christiaens Caroline J. Bax Mireille N. Bekker Catia M. Bilardo Elles M. J. Boon G. Heleen Schuring‐Blom Audrey B. C. Coumans Brigitte H. Faas Robert‐Jan H. Galjaard Attie T. Go Lidewij Henneman Merryn V. E. Macville Eva Pajkrt Ron F. Suijkerbuijk Karin Huijsdens‐van Amsterdam Diane Van Opstal E. J. (Joanne) Verweij Marjan M. Weiss Erik A. Sistermans

OBJECTIVE To evaluate the clinical impact of nationwide implementation of genome-wide non-invasive prenatal testing (NIPT) in pregnancies at increased risk for fetal trisomies 21, 18 and 13 (TRIDENT study). METHOD Women with elevated risk based on first trimester combined testing (FCT ≥ 1:200) or medical history, not advanced maternal age alone, were offered NIPT as contingent screening test,...

Journal: :Prenatal diagnosis 2015
Steven L Warsof Sebastian Larion Alfred Z Abuhamad

Noninvasive prenatal testing (NIPT) has had a profound influence in the field of prenatal diagnosis since the 1997 discovery of cell-free fetal DNA in maternal blood. Research has progressed rapidly, with clinical data supporting laboratory studies showing that NIPT is highly sensitive and specific for fetal aneuploidy, resulting in marked uptake in the high-risk patient population. The superio...

Journal: :South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde 2016
C N Mnyani E Nicolaou S Bister

BACKGROUND Concerns have been raised about the injudicious use of non-invasive prenatal testing (NIPT) using cell-free DNA (cfDNA), which often leads to inaccuracies in interpretation of the role and value of cfDNA in prenatal screening. OBJECTIVES  To determine the value and role of NIPT in a select South African (SA) population. METHODS  A retrospective review of patients who elected to h...

2014
Ruth M. Farrell Mary Beth Mercer Patricia K. Agatisa Marissa B. Smith Elliot Philipson

Noninvasive prenatal testing (NIPT) offers pregnant women a new risk assessment tool for fetal aneuploidy that is superior to conventional screening tests. We conducted focus groups with women who were currently pregnant or had recently delivered in the past year to characterize their perspectives about NIPT and to explore factors they would consider during decision making about its use. Women ...

Journal: :The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians 2016
Genevieve Fairbrother John Burigo Thomas Sharon Ken Song

OBJECTIVE To estimate the cost-effectiveness of fetal aneuploidy screening in the general pregnancy population using non-invasive prenatal testing (NIPT) as compared to first trimester combined screening (FTS) with serum markers and NT ultrasound. METHODS Using a decision-analytic model, we estimated the number of fetal T21, T18, and T13 cases identified prenatally, the number of invasive pro...

2015
Mi-Young Lee Dae-Yeon Cho Hye-Sung Won Ah Reum Hwang Bada Jeong Jihun Kim Mijin Oh

OBJECTIVE To evaluate the performance of Momguard, non-invasive prenatal test (NIPT) for detecting trisomy (T) 21, T18, T13, and sex-chromosome abnormalities recently developed in Korea. METHODS This preliminary study formed part of a large prospective cohort study conducted at Asan Medical Center, Seoul, Korea. Only pregnant women who underwent both NIPT and confirmatory karyotyping were inc...

2013
Huso Yi Nina Hallowell Sian Griffiths Tak Yeung Leung

BACKGROUND A newly introduced cell-free fetal DNA sequencing based non-invasive prenatal testing (DNA-NIPT) detects Down syndrome with sensitivity of 99% at early gestational stage without risk of miscarriage. Attention has been given to its public health implications; little is known from consumer perspectives. This qualitative study aimed to explore women's motivations for using, and percepti...

2014
Melissa Hill David Wright Rebecca Daley Celine Lewis Fiona McKay Sarah Mason Nicholas Lench Abigail Howarth Christopher Boustred Kitty Lo Vincent Plagnol Kevin Spencer Jane Fisher Mark Kroese Stephen Morris Lyn S Chitty

BACKGROUND Non-invasive prenatal testing (NIPT) for aneuploidies is now available through commercial companies in many countries, including through private practice in the United Kingdom (UK). Thorough evaluation of service delivery requirements are needed to facilitate NIPT being offered more widely within state funded healthcare systems such as the UK's National Health Service (NHS). Successf...

Journal: :Prenatal diagnosis 2015
Saskia Tamminga Rachèl V van Schendel Wieke Rommers Caterina M Bilardo Eva Pajkrt Wybo J Dondorp Merel van Maarle Martina C Cornel Lidewij Henneman

OBJECTIVE The aim of this study was to investigate health professionals' opinions toward offering noninvasive prenatal testing (NIPT) as first-tier screening test regardless of pregnant women's risk, and toward a potential broader range of disorders. METHODS A questionnaire completed by obstetric health professionals (n = 240) after an in-service NIPT training in the West and North of the Net...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید